Brief: Black Diamond Therapeutics Announces Restructuring Plan To Focus Resources On Bdtx-1535 And Extend Cash Runway

Black Diamond Therapeutics

07/10/2024 21:26

Black Diamond Therapeutics Inc  BDTX.O :
    * BLACK DIAMOND THERAPEUTICS ANNOUNCES RESTRUCTURING PLAN TO
FOCUS
RESOURCES ON BDTX-1535 AND EXTEND CASH RUNWAY
    * BLACK DIAMOND THERAPEUTICS INC - WILL DEPRIORITIZE
BDTX-4933 AND
SEEK POTENTIAL PARTNERS
    * BLACK DIAMOND THERAPEUTICS INC - COST SAVINGS EXPECTED TO
EXTEND
CASH RUNWAY INTO Q2 2026
    * BLACK DIAMOND THERAPEUTICS INC - RESTRUCTURING EXPECTED TO
FUND
OPERATIONS INTO Q2 2026
    * BLACK DIAMOND THERAPEUTICS - BLACK DIAMOND IS ACTIVELY
SEEKING
PARTNERSHIPS AS IT DEPRIORITIZES ITS BDTX-4933 PROGRAM IN
RAF/RAS-MUTANT SOLID TUMORS
    * BLACK DIAMOND THERAPEUTICS INC - CFO FANG NI AND CPO
ELIZABETH
MONTGOMERY DEPARTING BLACK DIAMOND
    * BLACK DIAMOND THERAPEUTICS- TO ENABLE FOCUSED INVESTMENT
IN
BDTX-1535, TAKEN STEPS TO OPTIMIZE OPERATIONS, INCLUDING A
REDUCTION IN FORCE

Source text for Eikon:  ID:nGNX8VM9yR 
Further company coverage:  BDTX.O